Sulprostone
![]() | |
Systematic (IUPAC) name | |
---|---|
(Z)-7-[(1R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number |
60325-46-4 ![]() |
ATC code | G02AD05 (WHO) |
PubChem | CID 5312153 |
ChemSpider | 4471583 |
UNII |
501Q5EQ1GM ![]() |
KEGG |
D02725 ![]() |
ChEMBL |
CHEMBL284178 ![]() |
Chemical data | |
Formula | C23H31NO7S |
Molar mass | 465.56 g/mol |
| |
| |
(verify) |
Sulprostone is an oxytocic.
It is an analogue of prostaglandin E2.[1]
References
- ↑ Tamma G, Wiesner B, Furkert J, et al. (August 2003). "The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho". Journal of Cell Science 116 (Pt 16): 3285–94. doi:10.1242/jcs.00640. PMID 12829746.
|
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.